Valirx Plc (VAL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 50 | 10 | 0 | 0 | 0 |
| Cost of Goods | 0 | 1 | N/A | N/A | N/A |
| Gross Profit | 50 | 8 | N/A | N/A | N/A |
| Operating Expenses | 2,191 | 2,307 | 2,593 | 1,678 | 1,651 |
| Operating Income | -2,142 | -2,299 | -2,593 | -1,678 | -1,651 |
| Interest Expense | 1 | 4 | 5 | 3 | 7 |
| Other Income | 12 | 0 | 0 | 0 | 114 |
| Pre-tax Income | -2,130 | -2,303 | -2,599 | -1,681 | -1,544 |
| Income Tax | -128 | -175 | -193 | -133 | -75 |
| Net Income Continuous | -2,003 | -2,128 | -2,406 | -1,547 | -1,468 |
| Minority Interests | 87 | 90 | 40 | 29 | 25 |
| Net Income | $-1,916 | $-2,038 | $-2,366 | $-1,518 | $-1,443 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.03 | -0.02 | -0.04 |
| EBITDA(a) | $-1,862 | $-2,044 | $-2,381 | $-1,449 | $-1,307 |